Alcohol consumption and colorectal cancer risk in prediabetes and diabetes: a nationwide cohort study.

Authors

Tae-Se Kim, Kyungdo Han, Young Eun Oh, Eun Ran Kim, Byung-Hoon Min

Published in

Journal of the National Cancer Institute. Sep 24, 2026. Epub Sep 24, 2026.

Abstract

The impact of light-to-moderate alcohol consumption on colorectal cancer (CRC) risk remains uncertain. We examined whether a dose-response association exists between alcohol consumption and CRC risk and whether it differs by glycemic status.
A nationwide cohort of 4,475,492 adults undergoing health screening provided by Korean National Health Insurance Service in 2012 was analyzed. Participants were followed until CRC development, death, or December 31, 2022 (median follow-up, 9.33 years). Alcohol intake was categorized as none, light-to-moderate (male, <30 g/day; female, <20 g/day), or heavy. Incident CRC identified using ICD-10-CM and cancer-specific reimbursement codes served as the primary outcome.
During follow-up, 51,592 participants developed CRC. Worse glycemic status was significantly associated with increased risk of CRC (hazard ratio [HR], 1.11 [95% CI, 1.09-1.13] for impaired fasting glucose (IFG); HR, 1.26 [95% CI, 1.23-1.29] for diabetes). Light-to-moderate alcohol consumption significantly and synergistically increased CRC risk in individuals with IFG (HR, 1.23 [95% CI, 1.19-1.27]; synergy index, 1.72 [95% CI, 1.40-2.04]) and in those with diabetes (HR, 1.48 [95% CI, 1.42-1.54]; synergy index, 2.04 [95% CI, 1.84-2.25]). Greater alcohol intake amount and frequency showed a linear dose-response association with increased risk of all subsites of colorectal cancer across all glycemic categories (except normoglycemia for proximal colon cancer), with the steepest gradient for diabetes.
Even light-to-moderate alcohol consumption was associated with increased CRC risk; therefore, strict restriction of alcohol intake may help reduce this risk, particularly among individuals with IFG or diabetes.

PMID:
42786582
Bibliographic data and abstract were imported from PubMed on 25 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.